Cargando…
Hyperphenylalaninemias genotyping: Results of over 60 years of history in Lombardy, Italy
BACKGROUND: Hyperphenylalaninemias (HPA) are due to several gene mutations, of which the PAH gene is the most frequently involved. Prevalence and incidence of disease vary between populations, with genotype/phenotype correlations not always capable to correctly predict disease severity. The aim of t...
Autores principales: | Rovelli, Valentina, Cefalo, Graziella, Ercoli, Vittoria, Zuvadelli, Juri, Olivia, Turri, Graziani, Daniela, Luisella, Alberti, Bassi, Davide, Re Dionigi, Alice, Selmi, Raed, Paci, Sabrina, Salvatici, Elisabetta, Banderali, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000623/ https://www.ncbi.nlm.nih.gov/pubmed/36537053 http://dx.doi.org/10.1002/edm2.396 |
Ejemplares similares
-
Telehealth and COVID-19: Empowering Standards of Management for Patients Affected by Phenylketonuria and Hyperphenylalaninemia
por: Rovelli, Valentina, et al.
Publicado: (2021) -
PKU and COVID19: How the pandemic changed metabolic control
por: Rovelli, Valentina, et al.
Publicado: (2021) -
L-alanine supplementation in Pompe disease (IOPD): a potential therapeutic implementation for patients on ERT? A case report
por: Rovelli, Valentina, et al.
Publicado: (2022) -
Low bone mineralization in phenylketonuria may be due to undiagnosed metabolic acidosis()
por: Rovelli, Valentina, et al.
Publicado: (2023) -
Breastfeeding in Phenylketonuria: Changing Modalities, Changing Perspectives
por: Zuvadelli, Juri, et al.
Publicado: (2022)